Table 1 Basic information of extracted patients from SEER diagnosed in 2010–2015
From: Comparison of metastasis between early-onset and late-onset gastric signet ring cell carcinoma
Variables | Total | Early-onset SRCC | Late-onset SRCC | P value |
|---|---|---|---|---|
Total | 2052 | 234 | 1818 | |
Sex | 0.0005 | |||
Male | 1034 (50.39%) | 94 (40.17%) | 949 (52.2%) | |
Female | 1009 (49.61%) | 140 (59.83%) | 869 (47.8%) | |
Race | 0.739 | |||
White | 1381 (67.3%) | 157 (67.1%) | 1224 (67.33%) | |
Black | 252 (12.28%) | 32 (13.67%) | 220 (12.1%) | |
Other | 419 (20.42%) | 45 (19.23%) | 374 (20.57% | |
Primary site | 0.013 | |||
Cardia | 283 (13.79%) | 20 (8.55%) | 263 (14.47%) | |
Fundus | 54 (2.63%) | 7 (2.99%) | 47 (2.59%) | |
Antrum | 1076 (52.44%) | 118 (50.43%) | 958 (52.7%) | |
Body | 232 (11.31%) | 39 (16.67%) | 193 (10.6%) | |
Overlappping/NOS | 407 (18.83%) | 50 (21.37%) | 357 (19.64%) | |
T stage | 0.657 | |||
Tis/T1 | 408 (19.88%) | 45 (19.23%) | 363 (19.97%) | |
T2 | 224 (10.92%) | 30 (12.82%) | 194 (10.67%) | |
T3 | 694 (33.82%) | 73 (31.2%) | 621 (34.16%) | |
T4 | 726 (35.38%) | 86 (36.75%) | 640 (35.2%) | |
N stage | 0.738 | |||
N0 | 731 (35.62%) | 86 (36.75%) | 645 (35.48%) | |
N1 | 357 (17.4%) | 37 (15.81%) | 320 (17.6%) | |
N2 | 346 (16.86%) | 44 (18.8%) | 302 (16.61%) | |
N3 | 638 (31.09%) | 67 (28.63%) | 551 (30.3%) | |
M stage | 0.000 | |||
M0 | 1818 (88.6% | 188 (80.34%) | 1630 (89.66%) | |
M1 | 234 (11.4%) | 46 (19.66%) | 188 (10.34%) | |
Tumor number | 0.000 | |||
1 | 1629 (79.39%) | 217 (92.74%) | 1412 (77.67%) | |
> 1 | 423 (20.61%) | 17 (7.26%) | 406 (22.33%) | |
Tumor size | 0.99 | |||
≤ 2 cm | 430 (20.96%) | 51 (21.79%) | 389 (21.4%) | |
≤ 5 cm | 793 (38.65%) | 90 (38.46%) | 703 (38.67%) | |
> 5 cm | 819 (39.91%0 | 93 (39.74%) | 726 (39.93%) | |
Examined LNs | 0.227 | |||
≤ 16 | 997 (48.59%) | 105 (44.87%) | 892 (49.06%) | |
> 16 | 1055 (51.41%) | 129 (55.13%) | 926 (50.94%) | |
Chemotherapy | 0.000 | |||
No | 1295 (63.11%) | 90 (38.46%) | 1205 (66.28%) | |
Yes | 757 (36.89%) | 144 (61.54%) | 613 (33.72%) |